- Staat
- FL
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 30.01.2023
- Impfdatum
- 14.01.2023
- Beginn
- 16.01.2023
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Headache
Injection site discharge
Injection site reaction
Pyrexia
Rash erythematous
Symptomtext
Patient said she started having symptoms 2 days after getting the vaccines. The injection site opened up and started leaking a clear fluid. She is having headaches, fever, fatigue and red spots on her skin.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 01.11.2022
- Impfdatum
- -
- Beginn
- 26.10.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure via eye contact
Eye pruritus
Ocular hyperaemia
Symptomtext
Provider now has a red and itchy right eye.; Priming an MMRII vaccine a small amount may have gotten in her right eye.; This spontaneous report has been received from a nurse practitioner referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported. On 26-OCT-2022, when the patient was priming a measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (lot number U013035 had been verified to be a valid number; expiration date 23-APR-2023, and upon internal validation established as the same date), for prophylaxis (dose, vaccination scheme, frequency, route of administration, anatomical site of injection were not reported) vaccine, a small amount may have gotten in her right eye (exposure via eye contact). It was reported that the event "occurred at approximately 14:40 Eastern Time. The patient now has a red and itchy right eye (ocular hyperaemia). She has experienced no vison changes or blurring at this time." The outcome of ocular hyperaemia was not provided. The causality assessment between measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) and the event ocular hyperaemia was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 26.08.2022
- Beginn
- 29.08.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Symptomtext
Pt's parent reported a full body rash 3 days after vaccination lasting 3 weeks. Per parent, sought care at a local urgent care where patient was given Kenalog.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- Unk
- Aktuelle Erkrankungen
- Unk
- Vorgeschichte
- None reported
- Andere Medikamente
- Unk
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 19.08.2022
- Impfdatum
- 16.08.2022
- Beginn
- 19.08.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site swelling
Rash
Rash pruritic
Symptomtext
Pain and swelling at site that resolved followed by wide spread rash. Scatterd bumps (red and skin colored) primarilly on torso and extremities. Also very itchy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Vit. C, Vit D, Multivitamin, and had used Cod Liver Oil
- Allergien
- NHDA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 10.10.2023
- Impfdatum
- 17.08.2023
- Beginn
- 17.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; RN calls to report MMR II Lot#u013035 exp 4/23/2023 administered to a patient. No further AE. No PQC; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 17-AUG-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, one time, lot #u013035, expiration date: 23-APR-2023, administered as prophylaxis (strength, and route of administration were not provided). No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.10.2023
- Impfdatum
- 08.08.2023
- Beginn
- 08.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
No further AE. No PQC; RN calls to report MMR II Lot#u013035 exp 4/23/2023 administered to a patient. No further AE. No PQC; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 08-AUG-2023, the patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, one time, lot #u013035, expiration date: 23-APR-2023, administered for prophylaxis (strength, and route of administration were not provided). On an unknown date, RN called to report MMR II Lot#u013035 exp 4/23/2023 administered to a patient. No further AE. No PQC. Lot Number u013035 is valid for V205c with albumin status rHa.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 11.05.2023
- Impfdatum
- 11.05.2023
- Beginn
- 11.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient was administered expired MMR vaccination SQ on Left Upper Arm at 2:50 PM (date of expiration: 4/23/23).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Patient will be offered titers and revaccination if indicated
- Aktuelle Erkrankungen
- No known problems
- Vorgeschichte
- No known health conditions
- Andere Medikamente
- Vitamin D3 25 mcg and Ferrous Sulfate 325 mg
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 27.04.2023
- Beginn
- 27.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
in error vaccine was administered that was 4 days expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 08.12.2022
- Impfdatum
- 03.12.2022
- Beginn
- 03.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
The patient has reported no adverse events to this reporter at this time; patient received an MMRII vaccine that was mixed with expired diluent; This spontaneous report has been received from a nurse practitioner, concerning a 42-years-old female patient. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided. On 03-DEC-2022, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant Human albumin) (M-M-R II) subcutaneous injection, in her right arm as prophylaxis (lot number U013035 has been verified to be valid; expiration date reported and established as 23-APR-2023) (strength, dose, frequency, vaccination scheme, and route of administration were not provided), diluted with sterile diluent solution for injection (lot number U035268 has been verified to be valid; expiration date reported and established as 09-NOV-2022) (expired product administered). The patient had reported no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 03.12.2022
- Impfdatum
- 03.12.2022
- Beginn
- 03.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Poor quality product administered
Product preparation issue
Symptomtext
Patient was given MMR vaccine with expired diluent. The MMR vaccine itself was not expired, but the diluent was.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Poor quality product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.11.2022
- Impfdatum
- 08.11.2022
- Beginn
- 08.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
No additional AE information provided.; HCP states that MMR II was accidentally administered to a patient via the intramuscular route instead of subcutaneously into the deltoid area.; This spontaneous report was received from Other Health Professional and refers to a patient of unknown and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 08-NOV-2022, the patient was vaccinated with measles, mumps, and rubella (WISTAR RA 27-3) virus vaccine, live rHA (M-M-R II) 0.5 milliliter, accidentally via the intramuscular route instead of subcutaneously (Incorrect route of product administration) into the deltoid area, valid lot #U013035, expiration date: 23-APR-2023, administered for prophylaxis (strength was not provided). No additional information or adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 02.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Incorrect product formulation administered
Symptomtext
Vaccines were drawn up and needles attached to pre drawn syringes by myself and another nurse for 2 clients coming in for immigration vaccines. I pulled Private vaccines for this clients, as this cilent had , while her partner had vaccines, which I pulled for him also. I accidently pulled out the pediatric dose of the Hep. B and upon adminstering it, I realized by the volume amount that it was, a pediatric dose was given and not an adult dose. So an Adult dose of Hep. B was given to the client after realizing the error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
No additional AEs or PQC reported.; Caller reported MMR II was administered IM instead of SQ. No other information provided. No additional AEs or PQC reported.; This spontaneous report was received from a registered nurse and refers to a patient of unspecified age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 21-JUL-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, 0.5 milliliter (also reported as mg), lot #U013035, expiration date: 23-APR-2023 (vaccination schedule was not provided) intramuscularly instead of subcutaneously, for prophylaxis (Incorrect route of product administration). No other information was provided, no additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 28.06.2022
- Impfdatum
- 31.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute flaccid myelitis
Symptomtext
Acute flaccid myelitis of the right arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute flaccid myelitis
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 21.06.2022
- Impfdatum
- 16.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered at inappropriate site
Symptomtext
Patient recieved four vaccines on June 16th, 2022. The MMRII Vaccine which is to be administered under the skin, was instead injected into the patient's deltoid muscle. Patient did not immediately complain of discomfort, and when contacted to return for proper administration, stated that she would return in 28 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered at inappropriate site
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Unknown
- Allergien
- Sulfa antibiotics
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 07.06.2022
- Beginn
- 07.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Patient was given Shingrix vaccination instead of Varicella
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 07.06.2022
- Impfdatum
- 17.05.2022
- Beginn
- 17.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
No adverse event; Medical assistant is reporting that a 4 year old female patient received a partial dose (5%) of MMR II on 5/17/2022. No additional AE reported. No PQC reported.; This spontaneous report was received from a medical assistant concerning a 4-year-old female patient. The patient's medical history, concurrent conditions, concomitant medication, and previous drugs reactions or allergies were not reported. On 17-MAY-2022, the patient was vaccinated with a partial dose (reported as 5%) (inappropriate dose of vaccine administered) of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant human albumin (rHA)) (M-M-R II) lot number U013035 and expiration date: 23-APR-2023 (strength, dose, route of administration and anatomical location were not reported) administered for prophylaxis. No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 22.03.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
no aditional AE; patient was administered MMR II intramuscularly in the tight instead of subcutaneously; This spontaneous report was received from a registered nurse and refers to a 12-month-old male patient. Information regarding the patient's pertinent medical history, concurrent conditions, drugs reactions or allergies were not provided. Concomitant therapies includes varicella virus vaccine live (Oka/Merck) (VARIVAX) and hepatitis A Vaccine, Inactivated (VAQTA). On 22-MAR-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), subcutaneous injection, 0.5 milliliter, lot number U013035 has been verified to be valid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date: 23-APR-2023, and sterile diluent (MERCK STERILE DILUENT) (lot number, expiry date). However, the vaccine was administered intramuscularly in the right tight instead of subcutaneously (incorrect route of product administration). No adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- VARIVAX; VAQTA; MERCK STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 06.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product preparation issue
Symptomtext
DILUANT GIVEN WITHOUT RECONSTITUTION WITH LYOPHILIZED POWDER. CALL PLACED TO CLIENT TO ADVISE OF ERROR. ADVISED CLIENT THAT SHE WILL NEED AN ADDITIONAL VACCINE IN 4 WEEKS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- HTN
- Vorgeschichte
- HTN
- Andere Medikamente
- AMLODIPINE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 25.03.2022
- Impfdatum
- 22.03.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect route of product administration
Symptomtext
MMR vaccine administered intramuscularly in the right thigh, instead of subcutaneously.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -